CLS participates in World Conference of Interventional Oncology 8-11 June in Boston, USA
Clinical Laserthermia Systems (CLS) (publ), is participating in WCIO 2017 (World Conference of Interventional Oncology) in Boston, USA. - This is the first time we are part of this conference, targeting one of our main user groups, interventional oncologists, said Dan Mogren, CCO at CLS. WCIO 2017 is an excellent forum for us to showcase our products and further expand our presence in the US market, said Dan Mogren. CLS develops and markets the TRANBERG®|Thermal Therapy System, as well as disposable materials and methods for heat-induced immunotherapy for safe and gentle treatment of